Could Artificial Intelligence/Machine Learning and Inclusion of Diet-Gut Microbiome Interactions Improve Disease Risk Prediction? Case Study: Coronary Artery Disease

Abstract

Coronary artery disease (CAD) is the most common cardiovascular disease (CVD) and the main leading cause of morbidity and mortality worldwide, posing a huge socio-economic burden to the society and health systems. Therefore, timely and precise identification of people at high risk of CAD is urgently required. Most current CAD risk prediction approaches are based on a small number of traditional risk factors (age, sex, diabetes, LDL and HDL cholesterol, smoking, systolic blood pressure) and are incompletely predictive across all patient groups, as CAD is a multi-factorial disease with complex etiology, considered to be driven by both genetic, as well as numerous environmental/lifestyle factors. Diet is one of the modifiable factors for improving lifestyle and disease prevention. However, the current rise in obesity, type 2 diabetes (T2D) and CVD/CAD indicates that the “one-size-fits-all” approach may not be efficient, due to significant variation in inter-individual responses. Recently, the gut microbiome has emerged as a potential and previously under-explored contributor to these variations. Hence, efficient integration of dietary and gut microbiome information alongside with genetic variations and clinical data holds a great promise to improve CAD risk prediction. Nevertheless, the highly complex nature of meals combined with the huge inter-individual variability of the gut microbiome poses several Big Data analytics challenges in modeling diet-gut microbiota interactions and integrating these within CAD risk prediction approaches for the development of personalized decision support systems (DSS). In this regard, the recent re-emergence of Artificial Intelligence (AI) / Machine Learning (ML) is opening intriguing perspectives, as these approaches are able to capture large and complex matrices of data, incorporating their interactions and identifying both linear and non-linear relationships. In this Mini-Review, we consider (1) the most used AI/ML approaches and their different use cases for CAD risk prediction (2) modeling of the content, choice and impact of dietary factors on CAD risk; (3) classification of individuals by their gut microbiome composition into CAD cases vs. controls and (4) modeling of the diet-gut microbiome interactions and their impact on CAD risk. Finally, we provide an outlook for putting it all together for improved CAD risk predictions.

Exploring the Landscape of Anti-Inflammatory Trials: A Comprehensive Review of Strategies for Targeting Inflammation in Acute Myocardial Infraction

“…The landscape is also marked by emerging trends that signify a paradigm shift in addressing inflammation-related CV risks. From harnessing the potential of artificial intelligence in data analysis to exploring the role of microbiota in CV health, these trends underscore the multidimensional nature of ongoing investigations [ 93 , 94 ]. In this direction, attention has been drawn toward inflamm-aging.…”

Role of Artificial Intelligence in Cardiovascular Risk Prediction and Prevention

“…Numerous research works have emphasised the shortcomings of traditional risk assessment instruments. According to a research by Patel et al, existing risk prediction models are insufficient for precisely identifying individuals who are high-risk [9]. This highlights the need for new risk indicators beyond traditional criteria.…”

“…Precision Medical Care and Tailored Solutions AI not only increases the accuracy of risk prediction but also makes personalised therapies in preventive cardiology possible. Clinicians can customise interventions and therapies to meet the specific needs of each patient by grouping patients according to their distinct risk profiles [9]. Targeted therapies are possible with this precision medicine approach, which also optimises healthcare resources and may lessen the burden of cardiovascular illnesses.…”

“…For example, a research by Smith et al found that by correctly predicting cardiovascular events in a varied patient group, AI-based risk models beat traditional risk scores [8]. Likewise, Johnson et al demonstrated how machine learning algorithms may effectively detect high-risk people who conventional risk calculators could have missed [9].…”

Artificial intelligence-based preventive, personalized and precision medicine for cardiovascular disease/stroke risk assessment in rheumatoid arthritis patients: a narrative review

“…This is due to the unique underlying pathophysiology of RA, which involves chronic inflammation, immune system dysregulation, vascular complications, and bone erosion [11]. To overcome the limitations of traditional risk assessment tools, there is research scope to forecast the CVD/Stroke threat in RA patients in a personalized framework using a combination of genomic and radiomics biomarkers along with traditional biomarkers [12].…”